CN113549649B - Preparation method of ginsenoside F1 - Google Patents
Preparation method of ginsenoside F1 Download PDFInfo
- Publication number
- CN113549649B CN113549649B CN202110895036.0A CN202110895036A CN113549649B CN 113549649 B CN113549649 B CN 113549649B CN 202110895036 A CN202110895036 A CN 202110895036A CN 113549649 B CN113549649 B CN 113549649B
- Authority
- CN
- China
- Prior art keywords
- ginsenoside
- tobacco
- gene
- ugtpn20
- pndds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XNGXWSFSJIQMNC-FIYORUNESA-N ginsenoside F1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@H](O)[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XNGXWSFSJIQMNC-FIYORUNESA-N 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- BGHNZAWRRWLKPO-UHFFFAOYSA-N Ginsenoside F1 Natural products CC(=C)CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C BGHNZAWRRWLKPO-UHFFFAOYSA-N 0.000 title description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 48
- 241000208125 Nicotiana Species 0.000 claims abstract description 46
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 34
- 230000009261 transgenic effect Effects 0.000 claims abstract description 29
- 102220358604 c.35C>A Human genes 0.000 claims abstract description 19
- 239000002773 nucleotide Substances 0.000 claims abstract description 12
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 abstract description 16
- 238000012546 transfer Methods 0.000 abstract description 7
- 230000002194 synthesizing effect Effects 0.000 abstract description 4
- 244000061176 Nicotiana tabacum Species 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- 241000196324 Embryophyta Species 0.000 description 21
- 241000589158 Agrobacterium Species 0.000 description 14
- 241000180649 Panax notoginseng Species 0.000 description 12
- 235000003143 Panax notoginseng Nutrition 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 229930027917 kanamycin Natural products 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 240000005373 Panax quinquefolius Species 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 229930182490 saponin Natural products 0.000 description 7
- 235000017709 saponins Nutrition 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000008186 active pharmaceutical agent Substances 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 5
- 229960001225 rifampicin Drugs 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 4
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000008130 triterpenoid saponins Chemical class 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 2
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- -1 protopanaxatriol saponin Chemical class 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- ZUXNULGHCOXCFL-UHFFFAOYSA-N 2-(4-tert-butyl-2,6-dimethylphenyl)acetonitrile Chemical compound CC1=CC(C(C)(C)C)=CC(C)=C1CC#N ZUXNULGHCOXCFL-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000000348 glycosyl donor Substances 0.000 description 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003521 tetracyclic triterpenoids Chemical class 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
本发明公开了一种人参皂苷F1的制备方法,该方法是将基因PnDDS、P12H、D6H和UGTPn20同时转入烟草中获得能够合成人参皂苷F1的转基因烟草,其中基因PnDDS的核苷酸序列如SEQ ID NO:1所示,基因P12H的核苷酸序列如SEQ ID NO:2所示,基因D6H的核苷酸序列如SEQ ID NO:3所示,基因UGTPn20的核苷酸序列如SEQ ID NO:4所示;实验结果显示本发明获得的转基因烟草植株能够合成人参皂苷F1,使得人参皂苷F1的获取更加高效便捷,且本发明方法简单,易操作,适于规模化生产和市场推广应用,本发明为获取人参皂苷F1提供了新途径。
The invention discloses a preparation method of ginsenoside F 1. The method is to simultaneously transfer genes PnDDS , P12H , D6H and UGTPn20 into tobacco to obtain transgenic tobacco capable of synthesizing ginsenoside F 1 , wherein the nucleotide sequence of the gene PnDDS is As shown in SEQ ID NO:1, the nucleotide sequence of gene P12H is shown in SEQ ID NO:2, the nucleotide sequence of gene D6H is shown in SEQ ID NO:3, and the nucleotide sequence of gene UGTPn20 is shown in SEQ ID NO:3 ID NO: 4; the experimental results show that the transgenic tobacco plants obtained by the present invention can synthesize ginsenoside F 1 , which makes the acquisition of ginsenoside F 1 more efficient and convenient, and the method of the invention is simple, easy to operate, and suitable for large-scale production and Market promotion and application, the invention provides a new way for obtaining ginsenoside F 1 .
Description
技术领域technical field
本发明属于生物医药制备技术领域,特别是一种在烟草中异源合成人参皂苷F1的方法。The invention belongs to the technical field of biological medicine preparation, in particular to a method for heterologous synthesis of ginsenoside F1 in tobacco.
背景技术Background technique
人参属植物一直以来都被用于治疗各种疾病和改善身体机能,其中三萜皂苷是人参属植物的主要活性成分。三萜皂苷具有促进细胞增殖、抑制细胞凋亡、抑制氧化应激、抗炎、增加细胞活力等多种药理作用,可对神经细胞、心肌细胞、肝细胞、肺上皮细胞等多种细胞发挥保护作用。Ginseng plants have been used to treat various diseases and improve bodily functions all the time, and triterpenoid saponins are the main active components of ginseng plants. Triterpenoid saponins have various pharmacological effects such as promoting cell proliferation, inhibiting cell apoptosis, inhibiting oxidative stress, anti-inflammatory, and increasing cell viability, and can protect nerve cells, cardiomyocytes, liver cells, lung epithelial cells and other cells. effect.
人参皂苷F1( ginsenoside F1 )为人参、三七、西洋参等药用植物中的稀有达玛烷型三萜皂苷成分,由PPT和糖基供体UDP-葡萄糖(UDP-glucose)经过UDP-葡萄糖基转移酶的催化作用生成的一种原人参三醇型皂苷,具有抗肿瘤、抗衰老、抗氧化等功效。人参皂苷F1对皮肤癌细胞B16的增殖和迁移以及黑色素的产生有很强的抑制作用,还可以保护由紫外线引起的对人体角质层HaCaT的损害。尽管人参皂苷F1具有重要的药理活性,但其在人参属药材中含量非常低,加之人参属物种为多年生植物,生长周期长,使得人参皂苷F1不易获得,价格昂贵,迫切需要开发获取人参皂苷F1的新方法和新途径。Ginsenoside F 1 ( ginsenoside F 1 ) is a rare dammarane-type triterpenoid saponin component in medicinal plants such as ginseng, Panax notoginseng and American ginseng. It is composed of PPT and glycosyl donor UDP-glucose (UDP-glucose) through UDP- A protopanaxatriol saponin produced by the catalysis of glucosyltransferase, has anti-tumor, anti-aging, anti-oxidation and other effects. Ginsenoside F 1 has a strong inhibitory effect on the proliferation and migration of skin cancer cells B16 and the production of melanin, and can also protect the damage to human stratum corneum HaCaT caused by ultraviolet rays. Although ginsenoside F 1 has important pharmacological activities, its content in the medicinal materials of the genus Ginseng is very low, and the species of ginseng is a perennial plant with a long growth cycle, which makes ginsenoside F 1 difficult to obtain and expensive. There is an urgent need to develop and obtain ginseng. Novel methods and routes for saponin F 1 .
烟草作为一种种植广泛,栽培技术成熟的经济作物,体内具有丰富的天然产物合成系统,并且烟草具备成熟的转基因技术体系。尽管烟草可能具备合成天然化合物的潜力,但尚未见到在烟草中合成人参皂苷F1的报道,且烟草基因组中没有发现合成包括人参皂苷F1在内的达玛烷型四环三萜皂苷的完整通路,说明烟草本身不具备合成此类皂苷的能力。Tobacco, as an economic crop with extensive planting and mature cultivation technology, has a rich natural product synthesis system in the body, and tobacco has a mature transgenic technology system. Although tobacco may have the potential to synthesize natural compounds, no reports of synthesizing ginsenoside F 1 in tobacco have been reported, and no dammarane-type tetracyclic triterpenoid saponins, including ginsenoside F 1 , have been found in the tobacco genome. The complete pathway indicates that tobacco itself does not have the ability to synthesize such saponins.
发明内容SUMMARY OF THE INVENTION
针对现有技术的不足,本发明提供了一种人参皂苷F1的制备方法,该方法通过在烟草中构建合成人参皂苷F1的途径,从而在烟草中产生人参皂苷F1,本发明提供一种获得人参皂苷F1的新途径;In view of the deficiencies of the prior art, the present invention provides a preparation method of ginsenoside F 1 , which produces ginsenoside F 1 in tobacco by constructing a method for synthesizing ginsenoside F 1 in tobacco. A new way to obtain ginsenoside F 1 ;
本发明方法是将基因PnDDS、P12H、D6H和UGTPn20同时转入烟草中获得能合成人参皂苷F1的转基因烟草,其中所述基因PnDDS的核苷酸序列如SEQ ID NO:1所示,基因P12H的核苷酸序列如SEQ ID NO:2所示,基因D6H的核苷酸序列如SEQ ID NO:3所示,基因UGTPn20的核苷酸序列如SEQ ID NO:4所示。The method of the invention is to simultaneously transfer genes PnDDS , P12H , D6H and UGTPn20 into tobacco to obtain transgenic tobacco capable of synthesizing ginsenoside F 1 , wherein the nucleotide sequence of the gene PnDDS is shown in SEQ ID NO: 1, the gene P12H The nucleotide sequence of the gene is shown in SEQ ID NO: 2, the nucleotide sequence of the gene D6H is shown in SEQ ID NO: 3, and the nucleotide sequence of the gene UGTPn20 is shown in SEQ ID NO: 4.
本发明目的通过以下技术方案实现:The object of the present invention is achieved through the following technical solutions:
(1)从三七(Panaxnotoginseng)根部提取总RNA,逆转录合成三七cDNA,以合成的第一链cDNA为模板,通过PCR扩增三七皂苷骨架合成酶基因PnDDS、骨架修饰酶基因P12H、骨架修饰酶基因D6H和骨架修饰酶基因UGTPn20,扩增引物如下:(1) Extract total RNA from the root of Panaxnotoginseng , reverse transcription to synthesize Panax notoginseng cDNA, and use the synthesized first-strand cDNA as a template to amplify the Panax notoginseng backbone synthase gene PnDDS , backbone modification enzyme gene P12H , The backbone modification enzyme gene D6H and the backbone modification enzyme gene UGTPn20 , the amplification primers are as follows:
PnDDS-Kpn I -F:5'-GGGTACCCCTGCAGATGTGGAAGCTGAA-3'; PnDDS-Kpn I- F:5'- GGGTACCCCTGCAGATGTGGAAGCTGAA -3';
PnDDS-Pst I-R:5'-TGCACTGCAGTGCACCCGGGTTAAATTTTGAGCT-3'; PnDDS-Pst I- R: 5'- TGCACTGCAGTGCA CCCGGGTTAAATTTTGAGCT-3';
P12H-Sac I-F:5'-CGAGCTCGATGGTGTTGTTTTTCTCCCTATCT-3'; P12H-Sac I- F: 5'- CGAGCTCG ATGGTGTTGTTTTTCTCCCTATCT-3';
P12H-Pst I -R:5'-TGCACTGCAGTGCATTAATTGTGGGGATGTAGATGAAT-3'; P12H-Pst I- R: 5'- TGCACTGCAGTGCA TTAATTGTGGGGATGTAGATGAAT-3';
D6H-Sac I-F:5'-CGAGCTCATGGATCTCTTTATCTCATCTC-3'; D6H - Sac I -F:5'- CGAGCTC ATGGATCTCTTTATCTCATCTC-3';
D6H-BamH I-R:5'-CGCGGATCCCAAGGTGATAGACGAATAGG-3'; D6H - BamH I -R: 5'- CGCGGATCCCAA GGTGATAGACGAATAGG-3';
UGTPn20-EcoR I-F:5'-GGAATTCCATAAATCTGGGAAAGGG-3'; UGTPn20 - EcoR I -F:5'- GGAATTCCATAAATCTGGGAAAGGG -3';
UGTPn20-Sac I–R:5'-CGAGCTCGCCAACAATAAAATCGTCACT-3'; UGTPn20 - Sac I --R:5'- CGAGCTCGCCAACAATAAAATCGTCACT -3';
(下划线为各自引物对应的酶切位点)(underlined are the corresponding restriction sites of the respective primers)
(2)将目的片段分别连接到pCAMBIA2300s植物表达载体上,并转化农杆菌;通过PCR筛选出阳性单克隆;(2) The target fragments were connected to the pCAMBIA2300s plant expression vector respectively, and transformed into Agrobacterium; positive single clones were screened by PCR;
(3)用含有目的基因的阳性农杆菌侵染烟草叶片,通过植株再生,获得含有PnDDS、P12H、D6H和UGTPn20四个基因的转基因烟草植株;(3) Infect tobacco leaves with positive Agrobacterium containing the target gene, and obtain transgenic tobacco plants containing four genes of PnDDS , P12H , D6H and UGTPn20 through plant regeneration;
(4)从阳性转基因烟草中提取其总RNA,逆转录为cDNA,进行RT-PCR确定四个基因是否表达;(4) Extract the total RNA from the positive transgenic tobacco, reverse-transcribe it into cDNA, and perform RT-PCR to determine whether the four genes are expressed;
(5)将转基因烟草的叶片烘干磨粉,甲醇浸泡过24h后超声提取皂苷,利用HPLC检测转基因烟草中人参皂苷的种类及其含量。(5) The leaves of transgenic tobacco were dried and ground, soaked in methanol for 24 hours, and then ultrasonically extracted saponins. The types and contents of ginsenosides in transgenic tobacco were detected by HPLC.
本发明优点和技术效果:Advantages and technical effects of the present invention:
本发明基于烟草种植容易、生长快速的特点,将分离自三七的基因PnDDS、P12H、D6H和UGTPn20同时转入烟草中,并获得能够同时表达PnDDS、P12H、D6H和UGTPn20四个基因的转基因烟草,实验结果显示本发明获得的转基因植株能够合成人参皂苷F1,使得人参皂苷F1的获取更加高效便捷,本发明方法简单,易操作,适于规模化生产和市场推广应用,本发明为获取人参皂苷F1提供了新途径。Based on the characteristics of easy planting and rapid growth of tobacco, the present invention simultaneously transfers genes PnDDS , P12H , D6H and UGTPn20 isolated from Panax notoginseng into tobacco, and obtains transgenic tobacco capable of simultaneously expressing four genes of PnDDS , P12H , D6H and UGTPn20 . , the experimental results show that the transgenic plant obtained by the present invention can synthesize ginsenoside F 1 , which makes the acquisition of ginsenoside F 1 more efficient and convenient. The method of the invention is simple, easy to operate, and suitable for large-scale production and market promotion and application. Ginsenoside F 1 provides a new approach.
附图说明Description of drawings
图1为基因PnDDS、P12H、D6H和UGTPn20 PCR产物电泳检测结果,图中M为DNAMarker;Fig. 1 is the electrophoresis detection result of gene PnDDS , P12H , D6H and UGTPn20 PCR products, and M in the figure is DNAMarker;
图2为四个基因转入农杆菌LBA4404的鉴定电泳图;Fig. 2 is the identification electropherogram of four genes transferred into Agrobacterium LBA4404;
其中A图为pCAMBIA2300s-DS;B图为pCAMBIA2300s-P12H;C图为 pCAMBIA2300s-D6H;D图为pCAMBIA2300s-UGTPn20,图中M为DNA Marker,1-5为阳性农杆菌菌株;“-”是水为模板;“+”是cDNA为模板;A picture is pCAMBIA2300s- DS ; B picture is pCAMBIA2300s -P12H ; C picture is pCAMBIA2300s- D6H ; D picture is pCAMBIA2300s -UGTPn20 , M in the figure is DNA Marker, 1-5 are positive Agrobacterium strains; "-" is water is the template; "+" is the cDNA template;
图3为转基因烟草中DNA的PCR验证电泳图,其中M为DNA Marker,WT为野生型烟草,T1-T6为转基因烟草,“+”是cDNA为模板;Fig. 3 is a PCR verification electropherogram of DNA in transgenic tobacco, wherein M is DNA Marker, WT is wild-type tobacco, T1-T6 is transgenic tobacco, and "+" is cDNA as template;
图4为转基因烟草中cDNA的PCR验证电泳图,其中M为DNA Marker,WT为野生型烟草,T1-T6为转基因烟草,“+”是cDNA为模板;Fig. 4 is a PCR verification electropherogram of cDNA in transgenic tobacco, wherein M is DNA Marker, WT is wild-type tobacco, T1-T6 is transgenic tobacco, and "+" is cDNA as template;
图5为转基因烟草中皂苷含量图,其中WT为野生型烟草,T4-T5为转基因烟草,DD为达玛烯二醇,PPD为原人参二醇,PPT为原人参三醇。Figure 5 is a graph of saponin content in transgenic tobacco, wherein WT is wild-type tobacco, T4-T5 is transgenic tobacco, DD is dammarediol, PPD is protopanaxadiol, and PPT is protopanaxatriol.
具体实施方式Detailed ways
下面通过实施例对本发明作进一步详细说明,但本发明保护范围不局限于所述内容,实施例中方法如无特殊说明均为常规方法,使用的试剂如无特殊说明均为常规市售试剂或按常规方法配制的试剂。The present invention will be described in further detail below through the examples, but the protection scope of the present invention is not limited to the content. The methods in the examples are conventional methods unless otherwise specified, and the reagents used are conventional commercially available reagents unless otherwise specified. Reagents prepared according to conventional methods.
实施例1: PnDDS、P12H、D6H和UGTPn20基因克隆Example 1: PnDDS , P12H , D6H and UGTPn20 gene cloning
以三七根为材料,用液氮将三七根研磨成粉末,然后转入离心管中,采用异硫氰酸胍法从三七根部提取总RNA,逆转录合成cDNA第一链,反应体系和操作过程为:取5μg TotalRNA,依次加入50ng oligo(dT)、2μL dNTP(2.5mM each)、DEPC水加至反应体积为14.5μL;混匀后,70℃加热变性5min后迅速在冰上冷却5min,然后依次加入4μL 5×First-standbuffer、0.5μLRNasin(200U)、1μL M-MLV(200U),混匀并短时离心,42℃温浴1.5h,取出后70℃加热10min,终止反应;以合成的第一链cDNA为模板,通过PCR扩增人参皂苷F1合成通路上的四个基因PnDDS、P12H、D6H和UGTPn20的开放阅读框序列,使用CE Design软件设计带同源臂的引物,扩增所用引物分别如下:Using Panax notoginseng root as material, grind Panax notoginseng root into powder with liquid nitrogen, then transfer it into a centrifuge tube, extract total RNA from Panax notoginseng root by guanidine isothiocyanate method, reverse transcription to synthesize the first strand of cDNA, the reaction system And the operation process is as follows: take 5μg TotalRNA, add 50ng oligo (dT), 2μL dNTP (2.5mM each), DEPC water in turn to the reaction volume of 14.5μL; after mixing, heat denaturation at 70°C for 5min, then quickly cool on
PnDDS-Kpn I -F:5'-GGGTACCCCTGCAGATGTGGAAGCTGAA-3'; PnDDS-Kpn I- F:5'- GGGTACCCCTGCAGATGTGGAAGCTGAA -3';
PnDDS-Pst I-R:5'-TGCACTGCAGTGCACCCGGGTTAAATTTTGAGCT-3'; PnDDS-Pst I- R: 5'- TGCACTGCAGTGCA CCCGGGTTAAATTTTGAGCT-3';
P12H-Sac I-F:5'-CGAGCTCGATGGTGTTGTTTTTCTCCCTATCT-3'; P12H-Sac I- F: 5'- CGAGCTCG ATGGTGTTGTTTTTCTCCCTATCT-3';
P12H-Pst I -R:5'-TGCACTGCAGTGCATTAATTGTGGGGATGTAGATGAAT-3'; P12H-Pst I- R: 5'- TGCACTGCAGTGCA TTAATTGTGGGGATGTAGATGAAT-3';
D6H-Sac I-F:5'-CGAGCTCATGGATCTCTTTATCTCATCTC-3'; D6H - Sac I -F:5'- CGAGCTC ATGGATCTCTTTATCTCATCTC-3';
D6H-BamH I-R:5'-CGCGGATCCCAAGGTGATAGACGAATAGG-3'; D6H - BamH I -R: 5'- CGCGGATCCCAA GGTGATAGACGAATAGG-3';
UGTPn20-EcoR I-F:5'-GGAATTCCATAAATCTGGGAAAGGG-3'; UGTPn20 - EcoR I -F:5'- GGAATTCCATAAATCTGGGAAAGGG -3';
UGTPn20-Sac I–R:5'-CGAGCTCGCCAACAATAAAATCGTCACT-3'; UGTPn20 - Sac I --R:5'- CGAGCTCGCCAACAATAAAATCGTCACT -3';
(下划线为各自引物对应的酶切位点)(underlined are the corresponding restriction sites of the respective primers)
PCR反应体系为50μL,包括:25μLPrime STAR MAX Premix、1μL上游引物F、1μL下游引物R 1μL 、1μLcDNA、22μLddH2O; PCR反应条件:98℃ 3min;98℃ 10 s,60℃ 15 s,72℃15 s,35个循环;72℃ 5min;PCR结束后,琼脂糖凝胶电泳检测,检测结果见图1,四个基因扩增条带大小分别为:2310bp、1503bp、1407bp和1423bp。扩增成功后使用SanPrep柱式DNA胶回收试剂盒(上海生工)进行目的条带回收:取1μL回收产物通过琼脂糖凝胶电泳检测回收片段的大小以及浓度,置于-20℃保存备用。The PCR reaction system was 50 μL, including: 25 μL Prime STAR MAX Premix, 1 μL upstream primer F, 1 μL
实施例2:植物表达载体构建Example 2: Plant expression vector construction
采用限制性内切酶对植物表达载体pCAMBIA2300s进行线性化,酶切体系为15μLpCAMBIA2300s质粒、5μL 10×M buffer、前后酶切位点的酶各2.5μL、25μLddH2O,混匀后短时离心,置于37℃酶切3.5h;将酶切产物点于琼脂糖凝胶中进行电泳,然后对pCAMBIA2300s载体大片段进行胶回收,整个过程使用SanPrep柱式DNA胶回收试剂盒(上海生工);取1μL回收产物通过琼脂糖凝胶电泳检测回收片段的大小以及浓度,置于-20℃保存备用。同源重组时,采用ClonExpressMultiS One Step Cloning Kit进行组装,将回收后的PnDDS、P12H、D6H和UGTPn20分别连接到pCAMBIA2300s植物表达载体上,反应体系(10μL)和操作过程:4μLpCAMBIA2300S载体DNA、目的片段 2μL、5×cell buffer 2μL、Exnase II 1μL、ddH2O 1μL,混匀后短时离心,然后37℃水浴反应30min;接着采用热激转化法将连接产物转入大肠杆菌DH5α中,涂布于含有50mg/L卡那霉素的LB固体培养基37℃培养24h;挑选单菌落在含有50mg/L卡那霉素的LB液体培养基中,37℃、200rpm摇菌,以菌液为模板分别用扩增四个基因的特异引物进行PCR,分别挑选出四个基因与pCAMBIA2300s成功连接的克隆,所检测的菌株若为阳性送测序公司检测,作进一步最终确认,最后对含有目的基因的大肠杆菌菌液加入甘油并置于-80℃保存备用。The plant expression vector pCAMBIA2300s was linearized with restriction endonucleases. The restriction enzyme digestion system was 15 μL pCAMBIA2300s plasmid, 5 μL 10×M buffer, 2.5 μL and 25 μL ddH 2 O for the enzymes at the front and rear restriction sites, and centrifuged for a short time after mixing. Digestion at 37°C for 3.5h; spot the digested product on agarose gel for electrophoresis, and then gel recovery of the large fragment of the pCAMBIA2300s vector. The whole process uses the SanPrep column DNA gel recovery kit (Shanghai Shenggong); Take 1 μL of the recovered product to detect the size and concentration of the recovered fragments by agarose gel electrophoresis, and store at -20°C for later use. During homologous recombination, the ClonExpressMultiS One Step Cloning Kit was used for assembly, and the recovered PnDDS , P12H , D6H and UGTPn20 were respectively connected to the pCAMBIA2300s plant expression vector. , 5×cell buffer 2μL, Exnase II 1μL, ddH 2 O 1μL, mix well, centrifuge for a short time, and then react in a water bath at 37°C for 30min; then use the heat shock transformation method to transfer the ligation product into Escherichia coli DH5α, spread on the The LB solid medium containing 50 mg/L kanamycin was cultured at 37°C for 24 hours; a single colony was selected in the LB liquid medium containing 50 mg/L kanamycin, and the bacteria were shaken at 37°C and 200 rpm. Amplify the specific primers of the four genes and perform PCR, and select the clones that successfully connect the four genes to pCAMBIA2300s. If the detected strains are positive, send them to a sequencing company for further final confirmation. Add glycerol to the solution and store at -80°C for later use.
采用SanPrep柱式质粒DNA小量抽提试剂盒提取大肠杆菌中的pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6H和pCAMBIA2300s-UGTPn20质粒,提取按试剂盒说明书进行;取1μL提取产物通过琼脂糖凝胶电泳检测回收片段的大小以及浓度,置于-20℃保存备用。The plasmids pCAMBIA2300s- DS , pCAMBIA2300s -P12H , pCAMBIA2300s- D6H and pCAMBIA2300s -UGTPn20 in Escherichia coli were extracted by SanPrep column plasmid DNA mini-extraction kit. The size and concentration of the recovered fragments were detected by electrophoresis, and stored at -20°C for later use.
实施例3:农杆菌介导的植物遗传转化以及转基因植物筛选Example 3: Agrobacterium-mediated plant genetic transformation and screening of transgenic plants
用液氮冻融法将上述构建的植物表达载体pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6H和pCAMBIA2300s-UGTPn20转入根癌农杆菌LBA4404感受态细胞中,操作步骤为:取2μg质粒加入含有200μL感受态细胞的离心管中,轻轻混匀后冰浴5min,随后转入液氮中冷冻1min,然后迅速置于37℃水浴5min,之后立即冰浴2min,加入800μL LB液体培养基后于28℃、200rpm振荡培养4h;将活化后的农杆菌涂于含有50mg/L卡那霉素和25mg/L利福平的LB固体培养基上,28℃静置培养48h左右;挑选单菌落摇菌,于含50mg/L卡那霉素和25mg/L利福平的LB液体培养基中28℃、200rpm振荡培养24h,最后用扩增四个基因的特异性引物进行PCR,明确pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6H和pCAMBIA2300s-UGTPn20质粒已转入农杆菌中;PCR检测结果如图2所示,得到5株转pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6H和pCAMBIA2300s-UGTPn20质粒的阳性农杆菌菌株,并且经测序验证,序列和原始序列完全一样,并且将菌种甘油保存于-80℃备用。The above-constructed plant expression vectors pCAMBIA2300s- DS , pCAMBIA2300s -P12H , pCAMBIA2300s- D6H and pCAMBIA2300s -UGTPn20 were transferred into Agrobacterium tumefaciens LBA4404 competent cells by liquid nitrogen freeze-thaw method. In the centrifuge tube of competent cells, mix gently and then ice bath for 5 minutes, then transfer to liquid nitrogen to freeze for 1 minute, then quickly place in 37°C water bath for 5 minutes, then immediately ice bath for 2 minutes, add 800 μL of LB liquid medium, and freeze at 28 Cultivate with shaking at 200rpm for 4h; spread the activated Agrobacterium on LB solid medium containing 50mg/L kanamycin and 25mg/L rifampicin, and incubate at 28°C for about 48h; select a single colony and shake the bacteria , in LB liquid medium containing 50mg/L kanamycin and 25mg/L rifampicin for 24h with shaking at 28°C and 200rpm. Finally, PCR was performed with specific primers for amplifying the four genes, and it was clear that pCAMBIA2300s- DS , The pCAMBIA2300s -P12H , pCAMBIA2300s- D6H and pCAMBIA2300s -UGTPn20 plasmids have been transformed into Agrobacterium; the PCR detection results are shown in Figure 2, and 5 strains were positive for the pCAMBIA2300s- DS , pCAMBIA2300s -P12H , pCAMBIA2300s- D6H and pCAMBIA2300s -UGTPn20 plasmids Agrobacterium strain, and verified by sequencing, the sequence is exactly the same as the original sequence, and the strain glycerol is stored at -80 ℃ for future use.
实施例4:农杆菌介导的烟草遗传转化Example 4: Agrobacterium-mediated genetic transformation of tobacco
本实验的转基因受体是烟草,将烟草种子用75%的酒精浸泡30s,用无菌水洗涤后用0.1%的HgCl2浸泡8min,然后再用无菌水洗涤若干次,播种于1/2 MS培养基上,28℃暗培养6d,发芽后转至光照培养箱(25℃,16 h/d光照),以后每月用1/2MS培养基继代一次。The transgenic receptor in this experiment is tobacco. Tobacco seeds were soaked in 75% alcohol for 30s, washed with sterile water, soaked in 0.1% HgCl for 8min , then washed with sterile water for several times, and sown in 1/2 The cells were cultured in the dark at 28 °C for 6 d on MS medium, transferred to a light incubator (25 °C, 16 h/d light) after germination, and then subcultured with 1/2 MS medium once a month.
从-80℃冰箱中取出保存的含有pCAMBIA2300s-DS、pCAMBIA2300s-P12H、pCAMBIA2300s-D6H和pCAMBIA2300s-UGTPn20质粒的农杆菌LBA4404菌种,将含有目的基因的农杆菌混合接种于含有50mg/L卡那霉素和20mg/L利福平的LB液体培养基中,28℃、200rpm培养至培养基浑浊;吸取1mL浑浊的混合菌液至含有50mg/L卡那霉素和20mg/L利福平的LB固体培养基上,28℃培养48 h;随后将LB固体培养基上的农杆菌刮下接种于添加有20mg/L的乙酰丁香酮的MGL液体培养基中,28℃振荡培养2-3h活化农杆菌。Take out the preserved Agrobacterium LBA4404 strain containing pCAMBIA2300s- DS , pCAMBIA2300s -P12H , pCAMBIA2300s- D6H and pCAMBIA2300s -UGTPn20 plasmids from the -80℃ refrigerator, and inoculate the Agrobacterium containing the target gene in a mixture containing 50 mg/L kanamycin In the LB liquid medium containing 50 mg/L rifampicin and 20 mg/L rifampicin, cultivate at 28°C and 200 rpm until the medium is turbid;
将1cm2大小的烟草叶片放入含有四种目的基因农杆菌的MGL液体培养基中,120rpm、28℃摇培20min;侵染结束后,用无菌滤纸将取出的烟草叶片的菌液吸干,然后再转接到含有40mg/L的乙酰丁香酮的MS固体培养基中,25℃左右,暗培养48 h;Put 1cm 2 size tobacco leaves into the MGL liquid medium containing four kinds of target gene Agrobacterium, 120rpm, 28 ℃ of shaking culture for 20min; after the infection is finished, the bacterial liquid of the tobacco leaves taken out is sucked dry with sterile filter paper , and then transferred to MS solid medium containing 40 mg/L acetosyringone, about 25 °C, and cultured in the dark for 48 h;
将共培养结束后的烟草叶片转移到筛选培养基(MS+0.5mg/L 6-BA+0.1mg/L NAA+50mg/L卡那霉素+300 mg/L头孢霉素)上进行选择培养,筛选培养时将培养瓶转移至光照培养箱培养(25℃,16 h/d光照,8 h/d黑暗),待烟草分化出芽后用含有50mg/L卡那霉素和300mg/L头孢霉素的MS培养基继代培养,因烟草愈伤分化率较高,故需要对再生植株进行进一步筛选,将烟草再生苗移至含有50mg/L卡那霉素的MS培养基上使其生根,最后选用生根较好的再生苗做进一步的检测。The tobacco leaves after co-cultivation were transferred to the selection medium (MS+0.5mg/L 6-BA+0.1mg/L NAA+50mg/L kanamycin+300 mg/L cephalosporin) for selection culture , transfer the culture flask to a light incubator (25°C, 16 h/d light, 8 h/d dark) during screening and culture. Subculture on the MS medium containing 50 mg/L of kanamycin, because the callus differentiation rate of tobacco is high, it is necessary to further screen the regenerated plants. Finally, the regenerated seedlings with better rooting were selected for further testing.
DNA水平检测,采用CTAB法提取转基因烟草叶片的DNA,以转基因植株的基因组DNA为模板,以扩增基因PnDDS、P12H、D6H和UGTPn20的特异引物进行PCR;PCR反应体系为2μLDNA、0.4μL 上游引物(10μM)、0.4μL下游引物(10μM)、10μL PCR Mix、7.2 μL ddH2O;PCR反应条件:94℃ 5min;94℃ 30s,60℃ 90s,72℃ 1min,32个循环;72℃ 7min;PCR结束后,取10μL产物用于琼脂糖凝胶电泳以检测阳性转基因植株,部分烟草转基因植株的扩增结果如图3所示,在DNA水平上检测获得6株阳性的植株。DNA level detection, the DNA of transgenic tobacco leaves was extracted by CTAB method, and the genomic DNA of transgenic plants was used as the template to conduct PCR with specific primers for amplifying genes PnDDS , P12H , D6H and UGTPn20 ; the PCR reaction system was 2 μL DNA, 0.4 μL upstream primers (10μM), 0.4μL downstream primer (10μM), 10μL PCR Mix, 7.2 μL ddH2O; PCR reaction conditions: 94°C 5min; 94°
RNA水平检测,取DNA水平上阳性转基因单株以及非转基因烟草(野生型)的嫩叶提取总RNA,总RNA提取的方法与实施例1中相同,逆转录生成cDNA第一链,并以此为模板用扩增PnDDS、P12H、D6H和UGTPn20基因的特异引物进行PCR;PCR反应体系为1.5μLcDNA、0.4μL上游引物(10μM)、0.4μL下游引物(10μM)、10μL PCR Mix、7.7μL ddH2O;PCR反应条件:94℃5min;94℃ 30s,60℃ 30s,72℃ 90s,32个循环;72℃ 7min;PCR结束后,取10μL用于琼脂糖凝胶电泳,根据PCR结果分析各转基因单株中PnDDS、P12H、D6H和UGTPn20四个基因转录水平的表达,PCR结束之后,取10μL用于琼脂糖凝胶电泳,部分单株的检测结果如图4所示,共检测到T4、T5转基因单株中PnDDS、P12H、D6H和UGTPn20四个基因在转录水平大量表达。RNA level detection, take the positive transgenic individual plant and non-transgenic tobacco (wild type) young leaves at the DNA level to extract total RNA, the method of total RNA extraction is the same as in Example 1, reverse transcription to generate the first strand of cDNA, and use this method PCR was performed with specific primers for the amplification of PnDDS , P12H , D6H and UGTPn20 genes as templates; the PCR reaction system was 1.5 μL cDNA, 0.4 μL upstream primer (10 μM), 0.4 μL downstream primer (10 μM), 10 μL PCR Mix, 7.7 μL ddH 2 O; PCR reaction conditions: 94°C for 5 min; 94°C for 30s, 60°C for 30s, 72°C for 90s, 32 cycles; 72°C for 7min; after PCR, take 10 μL for agarose gel electrophoresis, and analyze each transgene according to PCR results The expression levels of the four genes PnDDS , P12H , D6H and UGTPn20 in the individual plant, after the PCR, 10 μL was taken for agarose gel electrophoresis. The detection results of some individual plants are shown in Figure 4. A total of T4 and T5 were detected. Four genes, PnDDS , P12H , D6H and UGTPn20 , were abundantly expressed at the transcriptional level in transgenic plants.
实施例5:PnDDS、P12H、D6H和UGTPn20基因的表达对烟草合成人参皂苷F1的影响Example 5: Effects of PnDDS , P12H , D6H and UGTPn20 gene expression on tobacco synthesis of ginsenoside F 1
将转基因烟草的叶片烘干磨粉,称取1.0g烟叶粉末用50mL甲醇浸泡过24h后进行超声波60min,提取转基因烟草中皂苷,利用HPLC检测转基因烟草中人参皂苷的种类及其含量;具体的色谱条件为:高效液相色谱仪(安捷伦1260),色谱柱GRACE VisionHT C18 HL(250mm×4.6 mm,5µm),流动相为乙腈(A)/水(B),流速为1.0mL/min,柱温为30℃,检测波长203nm,采用乙腈(A)/水(B)进行梯度洗脱(v/v),梯度洗脱程序:0-20min,20%乙腈;20-30min,20%-35%乙腈;30-40min,35%乙腈; 40-50min,35-40%乙腈;50-60min,40-100%乙腈;结果如图5所示;其中在T5植株中,人参皂苷F1的含量最高,达到88.7µg/g DW(干重);同时也检测到其少量前体物质达玛烯二醇(DD)、原人参二醇(PPD)和原人参三醇(PPT)。The leaves of the transgenic tobacco were dried and ground into powder, and 1.0 g of tobacco leaf powder was weighed and soaked in 50 mL of methanol for 24 h, and then ultrasonicated for 60 min to extract the saponins in the transgenic tobacco. The types and contents of ginsenosides in the transgenic tobacco were detected by HPLC; Conditions are: high performance liquid chromatograph (Agilent 1260), column GRACE VisionHT C18 HL (250mm×4.6mm, 5µm), mobile phase is acetonitrile (A)/water (B), flow rate is 1.0mL/min, column temperature 30°C, detection wavelength 203nm, gradient elution (v/v) with acetonitrile (A)/water (B), gradient elution program: 0-20min, 20% acetonitrile; 20-30min, 20%-35% Acetonitrile; 30-40min, 35% acetonitrile; 40-50min, 35-40% acetonitrile; 50-60min, 40-100% acetonitrile; the results are shown in Figure 5; among them, ginsenoside F 1 has the highest content in T5 plants , reaching 88.7 µg/g DW (dry weight); a small amount of its precursors dammarediol (DD), protopanaxadiol (PPD) and protopanaxatriol (PPT) were also detected.
序列表sequence listing
<110> 昆明理工大学<110> Kunming University of Science and Technology
<120> 一种人参皂苷F1的制备方法<120> A kind of preparation method of ginsenoside F1
<160> 12<160> 12
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 2310<211> 2310
<212> DNA<212> DNA
<213> 三七(Panax notoginseng)<213> Panax notoginseng
<400> 1<400> 1
atgtggaagc tgaaggttgc tcaaggaaat gatccatatt tgtatagcac taacaacttt 60atgtggaagc tgaaggttgc tcaaggaaat gatccatatt tgtatagcac taacaacttt 60
gttggcagac aatattggga gtttcagccc gatgctggta ctccagaaga gagggaagag 120gttggcagac aatattggga gtttcagccc gatgctggta ctccagaaga gagggaagag 120
gttgaaaatg cacgcaagga ttatgtaaac aataaaaagc tacatggagt tcatccatgc 180gttgaaaatg cacgcaagga ttatgtaaac aataaaaagc tacatggagt tcatccatgc 180
agtgatatgc tgatgcgcag gcagcttatt aaagaaagtg gaatcgatct cctaagcata 240agtgatatgc tgatgcgcag gcagcttatt aaagaaagtg gaatcgatct cctaagcata 240
ccgccggtga gattagatga aaacgaacaa gtgaactacg atgcagttac aaccgctgtg 300ccgccggtga gattagatga aaacgaacaa gtgaactacg atgcagttac aaccgctgtg 300
aagaaagctc ttcgattgaa ccgggcaatt caagcacacg atggtcactg gccagctgaa 360aagaaagctc ttcgattgaa ccgggcaatt caagcacacg atggtcactg gccagctgaa 360
aatgcaggct ctttacttta tacacctccc cttatcattg ccctatatat cagcggaacg 420aatgcaggct ctttacttta tacacctccc cttatcattg ccctatatat cagcggaacg 420
attgacacta ttctgacaaa acaacacaag aaggaactga ttcgcttcgt ttacaaccat 480attgacacta ttctgacaaa acaacacaag aaggaactga ttcgcttcgt ttacaaccat 480
caaaatgagg atggtggatg gggatcctat attgaggggc acagcacgat gattgggtca 540caaaatgagg atggtggatg gggatcctat attgaggggc acagcacgat gattgggtca 540
gtacttagct tcgtgatgtt acgtttgcta ggagaaggat tagctgaatc tgatgatgga 600gtacttagct tcgtgatgtt acgtttgcta ggagaaggat tagctgaatc tgatgatgga 600
aatggtgcag ttgagagagg ccggaagtgg atacttgatc atggaggtgc agccagcata 660aatggtgcag ttgagagagg ccggaagtgg atacttgatc atggaggtgc agccagcata 660
ccctcttggg gaaagactta tctagcggtg cttggagtat atgagtggga agggtgcaac 720ccctcttggg gaaagactta tctagcggtg cttggagtat atgagtggga agggtgcaac 720
ccgctgcccc cagaattctg gcttttccct tcaagttttc cttttcatcc agcaaaaatg 780ccgctgcccc cagaattctg gcttttccct tcaagttttc cttttcatcc agcaaaaatg 780
tggatctact gccggtgtac ctacatgcca atgtcgtatt tgtatgggaa gagatatcat 840tggatctact gccggtgtac ctacatgcca atgtcgtatt tgtatgggaa gagatatcat 840
ggaccaataa ccgatcttgt tttatctttg agacaagaaa tttacaacat tccttatgag 900ggaccaataa ccgatcttgt tttatctttg agacaagaaa tttacaacat tccttatgag 900
cagataaagt ggaatcaaca gcgccataac tgttgcaagg aggatctcta ctaccctcat 960cagataaagt ggaatcaaca gcgccataac tgttgcaagg aggatctcta ctaccctcat 960
tcccttgtac aagacctggt ttgggatggt cttcactact ttagtgaacc attcctcaaa 1020tcccttgtac aagacctggt ttgggatggt cttcactact ttagtgaacc attcctcaaa 1020
cgttggccct tcaacaaact gcgaaaaaga ggtctaaaaa gagtggttga actaatgcgc 1080cgttggccct tcaacaaact gcgaaaaaga ggtctaaaaa gagtggttga actaatgcgc 1080
tatggtgcca ccgagaccag attcataacc acaggaaatg gggaaaaagc tttacaaata 1140tatggtgcca ccgagaccag attcataacc acaggaaatg gggaaaaagc tttacaaata 1140
atgagttggt gggcagaaga tcccaatggt gatgagttta aacatcacct tgctagaatt 1200atgagttggt gggcagaaga tcccaatggt gatgagttta aacatcacct tgctagaatt 1200
cctgatttct tatggattgc tgaggatgga atgacagtac agagttttgg tagtcaacta 1260cctgatttct tatggattgc tgaggatgga atgacagtac agagttttgg tagtcaacta 1260
tgggactgta ttcttgctac tcaagcaatt atcgccacca atatggttga agaatacgga 1320tgggactgta ttcttgctac tcaagcaatt atcgccacca atatggttga agaatacgga 1320
gattctctta agaaggcgca tttcttcatc aaagaatcgc agataaaaga aaatccaaga 1380gattctctta agaaggcgca tttcttcatc aaagaatcgc agataaaaga aaatccaaga 1380
ggagacttct taaaaatgtg tcgacagttt actaaaggtg cgtggacttt ctctgatcaa 1440ggagacttct taaaaatgtg tcgacagttt actaaaggtg cgtggacttt ctctgatcaa 1440
gatcatggtt gcgttgtctc ggactgcaca gctgaagcac taaagtgcct tctgttactt 1500gatcatggtt gcgttgtctc ggactgcaca gctgaagcac taaagtgcct tctgttactt 1500
tcacaaatgc cacaggacat tgtcggagaa aaacctaagg ttgagcgatt atatgaggct 1560tcacaaatgc cacaggacat tgtcggagaa aaacctaagg ttgagcgatt atatgaggct 1560
gtgaatgttc ttctctattt gcagagtcgt gtaagtggtg gcttcgcagt ttgggagcct 1620gtgaatgttc ttctctattt gcagagtcgt gtaagtggtg gcttcgcagt ttgggagcct 1620
ccagttccaa aaccatattt ggagatgttg aatccttcag aaatttttgc agacattgtt 1680ccagttccaa aaccatattt ggagatgttg aatccttcag aaatttttgc agacattgtt 1680
gttgagagag agcacattga atgcactgca tctgtaatca aaggtctgat ggcatttaaa 1740gttgagagag agcacattga atgcactgca tctgtaatca aaggtctgat ggcatttaaa 1740
tgcttgcatc ctgggcatcg tcagaaagag atagaggatt ctgtggcgaa agccatccgt 1800tgcttgcatc ctgggcatcg tcagaaagag atagaggatt ctgtggcgaa agccatccgt 1800
tatcttgaaa gaaaccaaat gcctgatggt tcatggtatg gcttttgggg aatttgtttc 1860tatcttgaaa gaaaccaaat gcctgatggt tcatggtatg gcttttgggg aatttgtttc 1860
ctctatggga cattttttac cctatcaggg tttgcttctg ctgggaggac ttatgacaac 1920ctctatggga cattttttac cctatcaggg tttgcttctg ctgggaggac ttatgacaac 1920
agtgaagcag ttcgtaaggg tgttaaattt ttcctttcaa cacaaaatga agaaggtggt 1980agtgaagcag ttcgtaaggg tgttaaattt ttcctttcaa cacaaaatga agaaggtggt 1980
tggggggaga gtcttgaatc atgcccaagc gagaaattta caccactcaa gggaaacagg 2040tggggggaga gtcttgaatc atgcccaagc gagaaattta caccactcaa gggaaacagg 2040
acaaatctag tacaaacatc atgggctatg ctaggtctta tgtttggtgg acaggccgag 2100acaaatctag tacaaacatc atgggctatg ctaggtctta tgtttggtgg acaggccgag 2100
agagatccga cacctctgca tagagcagcg aagttgttga tcaatgcgca aatggataat 2160agagatccga cacctctgca tagagcagcg aagttgttga tcaatgcgca aatggataat 2160
ggagatttcc ctcaacagga aattactgga gtatactgta aaaatagtat gttacattat 2220ggagatttcc ctcaacagga aattactgga gtatactgta aaaatagtat gttacattat 2220
gcggagtaca gaaatatatt tcctctttgg gcactcggag aatatcggaa acgtgtttgg 2280gcggagtaca gaaatatatt tcctctttgg gcactcggag aatatcggaa acgtgtttgg 2280
ttgccaaagc accagcagct caaaatttaa 2310ttgccaaagc accagcagct caaaatttaa 2310
<210> 2<210> 2
<211> 1503<211> 1503
<212> DNA<212> DNA
<213> 三七(Panax notoginseng)<213> Panax notoginseng
<400> 2<400> 2
atgcacatta cattcaatcc aaccaaaacc ttaggtgata tggcagcagc aatggtgttg 60atgcacatta cattcaatcc aaccaaaacc ttaggtgata tggcagcagc aatggtgttg 60
tttttctccc tatctcttct tctccttccc cttcccctat tattgtttgc ctatttttct 120ttttttctccc tatctcttct tctccttccc cttcccctat tattgtttgc ctatttttct 120
tatacaaaac gcatccccca gaaagaaaat gattcaaaag ctcccctccc ccccggtcaa 180tatacaaaac gcatccccca gaaagaaaat gattcaaaag ctcccctccc ccccggtcaa 180
acaggttggc ctttgatagg cgaaactctt aattatttat cttgtgtcaa aagtgggttt 240acaggttggc ctttgatagg cgaaactctt aattatttat cttgtgtcaa aagtgggttt 240
tctgaaaatt ttgtgaaata taggaaggaa aagtattccc ccaaagtttt caggacatct 300tctgaaaatt ttgtgaaata taggaaggaa aagtattccc ccaaagtttt caggacatct 300
cttttaggag aaccgatggc aatcttgtgt gggccggagg ggaacaaatt cctctactca 360ctttttaggag aaccgatggc aatcttgtgt gggccggagg ggaacaaatt cctctactca 360
acggaaaaaa agctagtcca aacttggttc ccgagcagtg ttgaaaagat gttccccaga 420acggaaaaaa agctagtcca aacttggttc ccgagcagtg ttgaaaagat gttccccaga 420
tctcatggcg aatccaacgc agacaacttc tccaaagtac gcggcaaaat gatgtttcta 480tctcatggcg aatccaacgc agacaacttc tccaaagtac gcggcaaaat gatgtttcta 480
ctcaaggtgg acgggctgaa aaaatatgtt ggcctaatgg acagggtgat gaaacagttt 540ctcaaggtgg acgggctgaa aaaatatgtt ggcctaatgg acagggtgat gaaacagttt 540
ttagagacgg attggaatcg ccaacaacaa atcaacgttc acaacacggt taagaaatac 600ttagagacgg attggaatcg ccaacaacaa atcaacgttc acaacacggt taagaaatc 600
acggtcacga tgtcgtgtcg ggtgtttatg agtatcgatg atgaagagca agtcagaaga 660acggtcacga tgtcgtgtcg ggtgtttatg agtatcgatg atgaagagca agtcagaaga 660
cttggcagct caattcagaa catagaggcc ggactcctcg ccgtgcctat aaatataccg 720cttggcagct caattcagaa catagaggcc ggactcctcg ccgtgcctat aaatataccg 720
gggactgcta tgaatcgtgc cattaagacc gtaaagttgc tatctagaga ggttgaggcg 780gggactgcta tgaatcgtgc cattaagacc gtaaagttgc tatctagaga ggttgaggcg 780
gtgattaagc aaagaaaagt ggatcttttg gagaataagc aagcgtccca accgcaagat 840gtgattaagc aaagaaaagt ggatcttttg gagaataagc aagcgtccca accgcaagat 840
ttattgtcac acttgctact tacggccaat caggatggcc agtttttgag cgaatcggat 900ttattgtcac acttgctact tacggccaat caggatggcc agtttttgag cgaatcggat 900
attgctagcc acttgatagg cttgatgcaa ggtggttata ccaccttaaa tggtacaatc 960attgctagcc acttgatagg cttgatgcaa ggtggttata ccaccttaaa tggtacaatc 960
accttcgtta tcaactatct tgcagagttt cctgatgtct acaatcaagt ccttaaagag 1020accttcgtta tcaactatct tgcagagttt cctgatgtct acaatcaagt ccttaaagag 1020
caagtggaaa tagcaaactc aaaacaccca aaagagttgc ttaattggga ggatttgagg 1080caagtggaaa tagcaaactc aaaacaccca aaagagttgc ttaattggga ggatttgagg 1080
aagatgaagt attcgtggaa tgttgctcaa gaggtattga gaataatacc accaggagtt 1140aagatgaagt attcgtggaa tgttgctcaa gaggtattga gaataatacc accaggagtt 1140
ggaacattca gagaggctat taccgacttc acctatgctg gatatttaat tccaaaggga 1200ggaacattca gagaggctat taccgacttc acctatgctg gatatttaat tccaaaggga 1200
tggaagatgc atctgattcc acatgacacg cacaagaacc caacatattt tccaaatcca 1260tggaagatgc atctgattcc acatgacacg cacaagaacc caacatattt tccaaatcca 1260
gaaaaattcg atccaaccag gtttgaagga aatggtccgg ctccatatac atttactcct 1320gaaaaattcg atccaaccag gtttgaagga aatggtccgg ctccatatac atttactcct 1320
ttcggaggag gacctcgaat gtgtccggga attgaatatg cacgtctagt aatactcatt 1380ttcggaggag gacctcgaat gtgtccggga attgaatatg cacgtctagt aatactcatt 1380
tttattcaca atgtggttac aaacttcaga tgggagaagc tcatccctag tgaaaaaatt 1440tttattcaca atgtggttac aaacttcaga tgggagaagc tcatccctag tgaaaaaatt 1440
ctcaccgatc cgattccaag atttgcgcat ggacttccaa ttcatctaca tccccacaat 1500ctcaccgatc cgattccaag atttgcgcat ggacttccaa ttcatctaca tccccacaat 1500
taa 1503taa 1503
<210> 3<210> 3
<211> 1407<211> 1407
<212> DNA<212> DNA
<213> 三七(Panax notoginseng)<213> Panax notoginseng
<400> 3<400> 3
atggatctct ttatctcatc tcaattactt cttctactag tcttttgctt attcctcttt 60atggatctct ttatctcatc tcaattactt cttctactag tcttttgctt attcctcttt 60
tggaatttca aaccaagtag ccaaaacaaa cttccccccg gcaaaacagg atggcccata 120tggaatttca aaccaagtag ccaaaacaaa cttccccccg gcaaaacagg atggcccata 120
attggagaaa cactagaatt catctcctgt ggccaaaaag gtaaccctga aaagttcgta 180attggagaaa cactagaatt catctcctgt ggccaaaaag gtaaccctga aaagttcgta 180
acacaaagaa tgaaaaaata ctcccctgat gtcttcacaa catccttagc aggcgagaaa 240acacaaagaa tgaaaaaata ctcccctgat gtcttcacaa catccttagc aggcgagaaa 240
atggtagttt tctgcggtgc ctyggggaac aaattcwttt tctccaasga aaacaagctt 300atggtagttt tctgcggtgc ctyggggaac aaattcwttt tctccaasga aaacaagctt 300
gttgtgtcct ggkggccccc tgccawwtcm aaaatcctaa ctgcaacaat accttcggta 360gttgtgtcct ggkggccccc tgccawwtcm aaaatcctaa ctgcaacaat accttcggta 360
gagaaaagca aagccttgcg gagtctaatt gttgaattct taaaacccga agcaytccac 420gagaaaagca aagccttgcg gagtctaatt gttgaattct taaaacccga agcaytccac 420
aagtttattt cggtcatgga tcggacaacg aggcagcact ttgaagccaa atggaacggg 480aagtttattt cggtcatgga tcggacaacg aggcagcact ttgaagccaa atggaacggg 480
agtacagaag tgaaagcttt cgctatgtca gagacgctga cttttgagtt ggcctgttgg 540agtacagaag tgaaagcttt cgctatgtca gagacgctga cttttgagtt ggcctgttgg 540
ctgctcttta gcataagtga tccggtgcag gtgcagaagc tttctcatct ttttgagaag 600ctgctcttta gcataagtga tccggtgcag gtgcagaagc tttctcatct ttttgagaag 600
gttaaagcgg gattattgtc tttaccttta aactttccgg gcacggcttt taaccgtggg 660gttaaagcgg gattattgtc ttaccttta aactttccgg gcacggcttt taaccgtggg 660
atcaaggccg ccaatcttat tagaaaagag ctttcggtgg tgataaaaca gaggagaagt 720atcaaggccg ccaatcttat tagaaaagag ctttcggtgg tgataaaaca gaggagaagt 720
gataaatcag agactcgaaa ggatcttttg tcccacgtta tgatttccaa tggcgagggc 780gataaatcag agactcgaaa ggatcttttg tcccacgtta tgatttccaa tggcgagggc 780
gagaaatttt tcagcgaaat ggatattgcg gacgttgttc ttaatatact gattgctagc 840gagaaatttt tcagcgaaat ggatattgcg gacgttgttc ttaatatact gattgctagc 840
catgatacca ctagcagtgc catgggctct gtggtctact ttcttgcaga tcatcctcac 900catgatacca ctagcagtgc catgggctct gtggtctact ttcttgcaga tcatcctcac 900
atctatgcta aagtcctcac agaacaaatg gagatcgcaa agtcgaaagg ggcaggagaa 960atctatgcta aagtcctcac agaacaaatg gagatcgcaa agtcgaaagg ggcaggagaa 960
cttttgagct gggacgacat caagaggatg aagtattccc gcaatgttat aaatgaagct 1020cttttgagct gggacgacat caagaggatg aagtattccc gcaatgttat aaatgaagct 1020
atgagattag tacctccttc tcaaggaggt tttaaagtag ttacaagtaa attcmgttac 1080atgagattag tacctccttc tcaaggaggt tttaaagtag ttacaagtaa attcmgttac 1080
gcmaacttca tcwttcccaa aggatggaar atcttttgga gcgkwwwctc gacacataaa 1140gcmaacttca tcwttcccaa aggatggaar atcttttgga gcgkwwwctc gacacataaa 1140
gatcccaaat actttaaaaa tccagaggag tttgatcctt caagatttga aggagatgga 1200gatcccaaat actttaaaaa tccagaggag tttgatcctt caagatttga aggagatgga 1200
cctatgccat tcacatttat accatttgga ggaggaccaa ggatgtgccc tgggagtgag 1260cctatgccat tcacatttat accatttgga ggaggaccaa ggatgtgccc tgggagtgag 1260
tttgctcgtc tggaggttct aatattcatg caccatttgg ttaccaattt taggtgggag 1320tttgctcgtc tggaggttct aatattcatg caccatttgg ttaccaattt taggtgggag 1320
aaggtgtttc ccaatgaaaa gattatttat actccatccc tcccggagaa tggtcttcct 1380aaggtgtttc ccaatgaaaa gattatttat actccatccc tcccggagaa tggtcttcct 1380
attcgtctat caccttgtac gctttaa 1407attcgtctat caccttgtac gctttaa 1407
<210> 4<210> 4
<211> 1423<211> 1423
<212> DNA<212> DNA
<213> 三七(Panax notoginseng)<213> Panax notoginseng
<400> 4<400> 4
atgaagtcag aattgatatt cttccttacg acggctcgga cacctcgtgg gatggtggag 60atgaagtcag aattgatatt cttccttacg acggctcgga cacctcgtgg gatggtggag 60
atggctaaac tcttcatcag tcgacatgaa aacctctcgg tcaccgtcct catcgcgaaa 120atggctaaac tcttcatcag tcgacatgaa aacctctcgg tcaccgtcct catcgcgaaa 120
ttctacatgg atacgggggt agacaactac aataaatcac tcttaacaaa gcctaccccg 180ttctacatgg atacgggggt agacaactac aataaatcac tcttaacaaa gcctaccccg 180
cgtctcacaa ttgtaaatct cccggaaagc gacccccaaa actatatgct caaaccacgc 240cgtctcacaa ttgtaaatct cccggaaagc gacccccaaa actatatgct caaaccacgc 240
cacgccatct ttcctagcgt catcgagact cagaagacac acgtgcgaga cataatatca 300cacgccatct ttcctagcgt catcgagact cagaagacac acgtgcgaga cataatatca 300
ggcatgactc agtccgagtc gactcgggtc gttggtttgc tggctgacct tttgttcatc 360ggcatgactc agtccgagtc gactcgggtc gttggtttgc tggctgacct tttgttcatc 360
ammmywwtkg rcattgccaa tgagttcaat gttccaactt atgtatactc ccctgccgga 420ammmywwtkg rcattgccaa tgagttcaat gttccaactt atgtatactc ccctgccgga 420
gcaggtcaty ttggcctygs gttccatytc cagacactca acgacaaaaa gcaagatgtg 480gcaggtcaty ttggcctygs gttccatytc cagacactca acgacaaaaa gcaagatgtg 480
accgagttca ggcactcgga cactgagtta ttggtaccga gttttgcaaa cccggttccc 540accgagttca ggcactcgga cactgagtta ttggtaccga gttttgcaaa cccggttccc 540
gccgaggtct tgccgtcgat gtatgtggat aaagaaggtg ggtatgatta tttgttttca 600gccgaggtct tgccgtcgat gtatgtggat aaagaaggtg ggtatgatta tttgttttca 600
ttgttccgga ggtgcagaga gtcaaaggca attattatta acacgtttga ggagctggaa 660ttgttccgga ggtgcagaga gtcaaaggca attattatta acacgtttga ggagctggaa 660
ccctatgcga tcaattccct ccggatggat agtatgatcc ctccgatcta cccggtggga 720ccctatgcga tcaattccct ccggatggat agtatgatcc ctccgatcta cccggtggga 720
cccatactaa atctcaacgg tgatggccaa aactccgatg aggctgctgt gatccttggt 780cccatactaa atctcaacgg tgatggccaa aactccgatg aggctgctgt gatccttggt 780
tggttagacg atcaaccacc ttcatctgtg gtgtttttgt gctttggtag ctatggaacc 840tggttagacg atcaaccacc ttcatctgtg gtgtttttgt gctttggtag ctatggaacc 840
tttcaagaaa accaggtgaa ggagattgca atgggtctag agcgcagtgg gcatcgcttc 900tttcaagaaa accaggtgaa ggagattgca atgggtctag agcgcagtgg gcatcgcttc 900
ttgtggtcct tgcgtccgtc tatccctaaa ggcgagacaa agcttcagct taaatactca 960ttgtggtcct tgcgtccgtc tatccctaaa ggcgagacaa agcttcagct taaatactca 960
aatttggaag aaattctccc agtcggattc ttggacagga catcatgcgt cggaaaagtt 1020aatttggaag aaattctccc agtcggattc ttggacagga catcatgcgt cggaaaagtt 1020
attggatggg ccccgcaagt ggcggtgcyc gracacgagg cagtcggagg gttcctgtct 1080attggatggg ccccgcaagt ggcggtgcyc gracacgagg cagtcggagg gttcctgtct 1080
cattgtggtt ggaattcgac attagagagt gtgtggtgtg gcgtgcccgt cgcaacatgg 1140cattgtggtt ggaattcgac attagagagt gtgtggtgtg gcgtgcccgt cgcaacatgg 1140
ccaatgtacg gcgagcaaca actcaatgct tttgagatgg ttaaggagtt gggtattgcg 1200ccaatgtacg gcgagcaaca actcaatgct tttgagatgg ttaaggagtt gggtattgcg 1200
gtggaaattg aggtggacta taagaatgaa tattttaaca tgacgaatga ttttattgtt 1260gtggaaattg aggtggacta taagaatgaa tattttaaca tgacgaatga ttttattgtt 1260
agggcagaag aaatcgagac gaaaataaag aagctgatga tggatgaaaa gaatagtgaa 1320agggcagaag aaatcgagac gaaaataaag aagctgatga tggatgaaaa gaatagtgaa 1320
ataaggaaga aggtaaagga aatgaaagaa aagagtaggc ttgcaatgtc tgagaatgga 1380ataaggaaga aggtaaagga aatgaaagaa aagagtaggc ttgcaatgtc tgagaatgga 1380
tcatcttata atcatgacga aggtatttga ggaaattatg taa 1423tcatcttata atcatgacga aggtatttga ggaaattatg taa 1423
<210> 5<210> 5
<211> 28<211> 28
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 5<400> 5
gggtacccct gcagatgtgg aagctgaa 28gggtacccct gcagatgtgg aagctgaa 28
<210> 6<210> 6
<211> 34<211> 34
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 6<400> 6
tgcactgcag tgcacccggg ttaaattttg agct 34tgcactgcag tgcacccggg ttaaattttg agct 34
<210> 7<210> 7
<211> 32<211> 32
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 7<400> 7
cgagctcgat ggtgttgttt ttctccctat ct 32cgagctcgat ggtgttgttt ttctccctat ct 32
<210> 8<210> 8
<211> 38<211> 38
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 8<400> 8
tgcactgcag tgcattaatt gtggggatgt agatgaat 38tgcactgcag tgcattaatt gtggggatgt agatgaat 38
<210> 9<210> 9
<211> 29<211> 29
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 9<400> 9
cgagctcatg gatctcttta tctcatctc 29cgagctcatg gatctcttta tctcatctc 29
<210> 10<210> 10
<211> 29<211> 29
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 10<400> 10
cgcggatccc aaggtgatag acgaatagg 29cgcggatccc aaggtgatag acgaatagg 29
<210> 11<210> 11
<211> 25<211> 25
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 11<400> 11
ggaattccat aaatctggga aaggg 25ggaattccat aaatctggga aaggg 25
<210> 12<210> 12
<211> 28<211> 28
<212> DNA<212> DNA
<213> 人工序列(Artificial)<213> Artificial Sequence (Artificial)
<400> 12<400> 12
cgagctcgcc aacaataaaa tcgtcact 28cgagctcgcc aacaataaaa tcgtcact 28
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110895036.0A CN113549649B (en) | 2021-08-05 | 2021-08-05 | Preparation method of ginsenoside F1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110895036.0A CN113549649B (en) | 2021-08-05 | 2021-08-05 | Preparation method of ginsenoside F1 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113549649A CN113549649A (en) | 2021-10-26 |
CN113549649B true CN113549649B (en) | 2022-07-01 |
Family
ID=78105320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110895036.0A Active CN113549649B (en) | 2021-08-05 | 2021-08-05 | Preparation method of ginsenoside F1 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113549649B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113493795B (en) * | 2021-08-03 | 2022-10-28 | 昆明理工大学 | Preparation method of ginsenoside Rh2 |
CN115725620B (en) * | 2022-09-12 | 2023-09-15 | 昆明理工大学 | Method for synthesizing panax japonicus saponins in pseudo-ginseng cells |
CN116656727B (en) * | 2023-06-12 | 2024-04-16 | 昆明理工大学 | Preparation method of panax japonicus saponin IVa |
CN117187297B (en) * | 2023-09-07 | 2024-08-23 | 昆明理工大学 | Method for synthesizing ginsenoside CK in ginseng cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110438099A (en) * | 2018-05-04 | 2019-11-12 | 中国科学院天津工业生物技术研究所 | The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1 |
CN113493795A (en) * | 2021-08-03 | 2021-10-12 | 昆明理工大学 | Preparation method of ginsenoside Rh2 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101788608B1 (en) * | 2014-04-30 | 2017-10-24 | 한국과학기술원 | A novel method for glycosylation of ginsenoside using a glycosyltransferase derived from panax ginseng |
-
2021
- 2021-08-05 CN CN202110895036.0A patent/CN113549649B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110438099A (en) * | 2018-05-04 | 2019-11-12 | 中国科学院天津工业生物技术研究所 | The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1 |
CN113493795A (en) * | 2021-08-03 | 2021-10-12 | 昆明理工大学 | Preparation method of ginsenoside Rh2 |
Non-Patent Citations (9)
Title |
---|
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1;Ko SR等;《Chem Pharm Bull (Tokyo)》;20030430;第51卷(第4期);404-408 * |
Functional regulation of a UDP-glucosyltransferase gene (Pq3-O-UGT1) by RNA interference and overexpression in Panax quinquefolius;Chao Lu等;《Plant Cell》;20170217;第129卷;445–456 * |
Liu,M.H.等;Panax notoginseng isolate CL13820Contig1_DS dammarenediol-II syn;《GenBank Database》;20150428;Accession No.KJ804174.1 * |
The chromosome-level reference genome assembly for Panax notoginseng and insights into ginsenoside biosynthesis;Jiang Z等;《Plant Commun》;20200920;第2卷(第1期);100113 * |
三七总皂苷(PNS)肠溶缓释片制备工艺及体外释放研究;张琳等;《时珍国医国药》;20190420(第04期);99-103 * |
人参皂苷生物合成关键酶基因DS与D12H的异源共表达研究;安岩;《中国优秀博硕士学位论文全文数据库(硕士)基础科学辑》;20141015(第10期);A006-48 * |
人参皂苷糖基转移酶基因研究概述;林廷文等;《中国中药杂志》;20201231(第19期);44-51 * |
生物转化法制备稀有人参皂苷及其生物活性研究;李瑞婷;《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》;20210515(第05期);E057-112 * |
调控三七皂苷生物合成PnERF转录因子的克隆与功能研究;卢荣江;《中国优秀博硕士学位论文全文数据库(硕士)基础科学辑》;20190315(第03期);A006-48 * |
Also Published As
Publication number | Publication date |
---|---|
CN113549649A (en) | 2021-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113549649B (en) | Preparation method of ginsenoside F1 | |
CN109295080B (en) | The use of ginseng β-arosinol synthase gene Pjβ-AS | |
CN103103194B (en) | Gene promoter of ginseng PgPDR3 responded by methyl jasmonate and application thereof | |
CN103088027B (en) | PDR transport protein gene promoter for controlling ginsenoside accumulation, and its application | |
CN110628808B (en) | Arabidopsis AtTCP5 gene and application thereof in regulating plant height | |
CN102676578B (en) | Method for increasing artemisinin content in sweet wormwood by DBR2 (double bond reductase 2) gene transfer | |
CN107267526B (en) | Panax notoginseng MYB transcription factor gene PnMYB2 and its application | |
CN110452291B (en) | Application of dendrobium officinale embryo development late-stage abundant protein DoLEA43 in promotion of plant callus formation | |
CN113493795B (en) | Preparation method of ginsenoside Rh2 | |
CN102876713B (en) | The Method of Transgenic Simultaneously Increasing the Contents of Rosmarinic Acid and Salvianolic Acid B in Salvia Miltiorrhiza | |
CN101186912A (en) | Method for increasing terpene lactone content in ginkgo callus by transgenic ggpps gene | |
CN118638820A (en) | Chalcone synthase gene of Lonicera japonica and its application in increasing the content of flavonoids in plants | |
CN109971744B (en) | A Malan BcTSA gene and its encoded protein and application | |
CN115725620B (en) | Method for synthesizing panax japonicus saponins in pseudo-ginseng cells | |
CN117568386A (en) | A method for producing notoginsenoside R1 from Gynostemma pentaphylla | |
CN117844793A (en) | Application of oxidation squalene cyclization gene NiOSC2 in biosynthesis | |
CN103103193B (en) | Ginseng PDR transmembrane transport protein gene promoter and application thereof | |
CN102925458B (en) | ABC transporter PgPDR2 gene and encoding protein and application of ABC transporter gene PgPDR2 | |
CN110157714B (en) | Safflower CtXTH1 gene, its encoded protein and application | |
CN116656727B (en) | Preparation method of panax japonicus saponin IVa | |
CN105695507B (en) | Method for improving artemisinin content in sweet wormwood herb by transferring ICS1 gene | |
CN118027166B (en) | Application of the transcription factor GsNSP1 of Desmodium sibiricum and its encoding gene | |
CN117187297B (en) | Method for synthesizing ginsenoside CK in ginseng cells | |
CN118703554B (en) | Application of Lotus NnXTH22 Gene in Increasing Plant Height and Stem Thickness | |
CN115927280B (en) | Horse Chestnut 2,3-Oxysqualene Cyclase and Its Encoding Gene and Application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |